Outcomes of sacral neuromodulation in male patients with overactive bladder, chronic pelvic pain, and fecal incontinence.

IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY
Canadian Journal of Urology Pub Date : 2024-08-01
Roseanne Ferreira, Emad Alwashmi, Samuel Otis-Chapados, Naeem Bhojani, Kevin C Zorn, Bilal Chughtai, Dean S Elterman
{"title":"Outcomes of sacral neuromodulation in male patients with overactive bladder, chronic pelvic pain, and fecal incontinence.","authors":"Roseanne Ferreira, Emad Alwashmi, Samuel Otis-Chapados, Naeem Bhojani, Kevin C Zorn, Bilal Chughtai, Dean S Elterman","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Despite the growing body of literature on sacral neuromodulation (SNM) outcomes, research focusing on male patients remains limited and often represented by small cohorts nested within a larger study of mostly women. Herein, we evaluated the outcomes of SNM in a male-only cohort with overactive bladder (OAB), fecal incontinence (FI), chronic bladder pain, and neurogenic lower urinary tract dysfunction (NLUTD).</p><p><strong>Materials and methods: </strong>This retrospective cohort study included 64 male patients who underwent SNM insertion between 2013 and 2021 at a high-volume tertiary center. Indications for SNM therapy included OAB, FI, chronic pelvic pain, and NLUTD. Descriptive statistics, Fisher's and t-test were used in analysis.</p><p><strong>Results: </strong>The mean age was 57.7 ± 13.4 years, and the most frequent reason for SNM insertion was idiopathic OAB (72%), FI (16%), pelvic pain (11%), and NLUTD (11%). A majority (84%) of men received treatment prior to SNM insertion. 84% reported satisfaction and 92% symptom improvement within the first year, and these improvements persisted beyond 1 year in 73% of patients. Mean follow up was 52.7 ± 21.0 months. The complication rate was 23%, and the need for adjunct treatments was significantly reduced (73% to 27%, p < 0.001). Treatment outcomes did not differ significantly between various indications for SNM therapy or the presence of benign prostatic hyperplasia (BPH).</p><p><strong>Conclusion: </strong>SNM is an effective and safe procedure for male patients with neurogenic and non-neurogenic OAB, pelvic pain, and FI. Over 70% of patients experienced symptomatic improvement and remained satisfied in the mid to long term follow up. BPH does not seem to hinder treatment outcomes.</p>","PeriodicalId":56323,"journal":{"name":"Canadian Journal of Urology","volume":"31 4","pages":"11943-11949"},"PeriodicalIF":1.2000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Urology","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Despite the growing body of literature on sacral neuromodulation (SNM) outcomes, research focusing on male patients remains limited and often represented by small cohorts nested within a larger study of mostly women. Herein, we evaluated the outcomes of SNM in a male-only cohort with overactive bladder (OAB), fecal incontinence (FI), chronic bladder pain, and neurogenic lower urinary tract dysfunction (NLUTD).

Materials and methods: This retrospective cohort study included 64 male patients who underwent SNM insertion between 2013 and 2021 at a high-volume tertiary center. Indications for SNM therapy included OAB, FI, chronic pelvic pain, and NLUTD. Descriptive statistics, Fisher's and t-test were used in analysis.

Results: The mean age was 57.7 ± 13.4 years, and the most frequent reason for SNM insertion was idiopathic OAB (72%), FI (16%), pelvic pain (11%), and NLUTD (11%). A majority (84%) of men received treatment prior to SNM insertion. 84% reported satisfaction and 92% symptom improvement within the first year, and these improvements persisted beyond 1 year in 73% of patients. Mean follow up was 52.7 ± 21.0 months. The complication rate was 23%, and the need for adjunct treatments was significantly reduced (73% to 27%, p < 0.001). Treatment outcomes did not differ significantly between various indications for SNM therapy or the presence of benign prostatic hyperplasia (BPH).

Conclusion: SNM is an effective and safe procedure for male patients with neurogenic and non-neurogenic OAB, pelvic pain, and FI. Over 70% of patients experienced symptomatic improvement and remained satisfied in the mid to long term follow up. BPH does not seem to hinder treatment outcomes.

膀胱过度活动症、慢性骨盆疼痛和大便失禁男性患者的骶神经调节疗效。
简介:尽管有关骶神经调控(SNM)疗效的文献越来越多,但针对男性患者的研究仍然有限,而且往往是嵌套在以女性为主的大型研究中的小型队列。在此,我们评估了膀胱过度活动症(OAB)、大便失禁(FI)、慢性膀胱痛和神经源性下尿路功能障碍(NLUTD)男性队列的骶神经调节治疗效果:这项回顾性队列研究纳入了 2013 年至 2021 年期间在一家大容量三级医疗中心接受 SNM 植入术的 64 名男性患者。SNM治疗的适应症包括OAB、FI、慢性盆腔疼痛和NLUTD。分析中使用了描述性统计、费雪检验和 t 检验:平均年龄为 57.7 ± 13.4 岁,插入 SNM 的最常见原因是特发性 OAB(72%)、FI(16%)、盆腔疼痛(11%)和 NLUTD(11%)。大多数男性(84%)在植入 SNM 之前接受了治疗。84%的患者表示满意,92%的患者在第一年内症状有所改善,73%的患者在一年后症状持续改善。平均随访时间为 52.7 ± 21.0 个月。并发症发生率为 23%,对辅助治疗的需求显著降低(从 73% 降至 27%,p < 0.001)。不同的SNM治疗适应症或良性前列腺增生症(BPH)的治疗效果没有明显差异:对于患有神经源性和非神经源性 OAB、盆腔疼痛和 FI 的男性患者来说,SNM 是一种有效而安全的治疗方法。70%以上的患者症状得到改善,并在中长期随访中保持满意。良性前列腺增生似乎并不妨碍治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Canadian Journal of Urology
Canadian Journal of Urology UROLOGY & NEPHROLOGY-
CiteScore
1.90
自引率
0.00%
发文量
86
审稿时长
6-12 weeks
期刊介绍: The CJU publishes articles of interest to the field of urology and related specialties who treat urologic diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信